Alibaba says it has developed AI to help detect heart disease

Huge impact on diagnosis if paper is proven true

20190710 alibaba.jpg

Alibaba DAMO Academy's vision computing division has so far diagnosed 10 million patients using an AI-based pulmonary nodule detection technology.  © Reuters

DUN YUTING, 36Kr

BEIJING -- Chinese internet conglomerate Alibaba Group Holding has submitted a paper that claims it has successfully developed cardiovascular recognition technology, which if proven true, will have wide-ranging impact on the diagnosis and treatment of heart disease.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.